Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring <i>c-Kit</i> Mutation or Amplification
PaperCitations, authors & open-access status
Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring <i>c-Kit</i> Mutation or Amplification is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 680 citations, 2011 year and bronze oa status.
680
Citations
2011
Year
bronze
OA Status